Crossmark

Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma

Crossref DOI link: https://doi.org/10.1007/s11060-018-03017-7

Published Online: 2018-11-03

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nickel, Ann-Christin

Wan, Xue-Yan

Saban, Dino-Vitali

Weng, Yin-Lun

Zhang, Shu

Keyvani, Kathy

Sure, Ulrich

Zhu, Yuan https://orcid.org/0000-0002-5908-0768
Funding

Funding for this research was provided by:

IFORES
License Information

Text and Data Mining valid from 2018-11-03
More Information

Article History

Received: 20 July 2018

Accepted: 25 September 2018

First Online: 3 November 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All applicable international, national, and /or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. The University of Duisburg-Essen approved all animal experiments (No. 84-02.04.2012.A348).

: For this type of study formal consent is not required.

: This article does not contain any studies with human participants performed by any of the authors.